Weight gain can contribute to insulin resistance, diabetes risk and cardiovascular burden, but it is not the only determinant of metabolic health. Some drug effects on glucose and lipids may occur without large visible weight changes. Blood pressure, smoking, family history and other conditions also influence long-term risk.<\/p>\n
Weight gain can occur during antipsychotic treatment, with substantial differences between medicines and individuals. Appetite, energy balance, sedation and direct physiological effects may all contribute. The issue is not adequately explained by willpower, and changes in weight should be considered alongside glucose, lipids, physical health and the benefits of psychiatric treatment.<\/p>\n
Assessment therefore looks beyond the scale. Monitoring may include waist measures, blood pressure, glucose or glycated haemoglobin and lipids according to clinical guidance. Results need interpretation and a follow-up plan rather than collection alone. Physical symptoms should not be dismissed because someone has schizophrenia. Management can involve primary care, the mental health team and relevant specialists. The aim is integrated care that addresses preventable illness while preserving effective psychiatric treatment. Population risks should inform support without assuming that every person will develop the same complication or outcome.<\/p>\n
Metabolic risk is assessed through several measures because each captures something different. Glucose relates to sugar regulation, lipids to circulating fats and blood pressure to cardiovascular strain. Weight is relevant but does not replace these checks. Explaining the measures helps the person understand why follow-up remains useful even if they have not noticed a large visible change.<\/p>\n
Further reading:<\/strong> DailyMed prescribing information<\/a>; Research record 17360666<\/a>; Research record 15855345<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Weight gain can contribute to insulin resistance, diabetes risk and cardiovascular burden, but it is not the only determinant of metabolic health. Some drug effects on glucose and lipids may occur without large visible weight\u2026Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[53],"class_list":["entry","author-","has-excerpt","post-759","post","type-post","status-publish","format-standard","category-medication-effects","tag-weight-gain"],"brizy_media":[],"_links":{"self":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/posts\/759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=759"}],"version-history":[{"count":0,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=\/wp\/v2\/posts\/759\/revisions"}],"wp:attachment":[{"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/schizophrenia.world\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}